Helius Medical Technologies Inc (HSDT)
2.66
-0.93
(-25.90%)
USD |
NASDAQ |
May 02, 16:00
2.86
+0.20
(+7.52%)
After-Hours: 20:00
Helius Medical Technologies Gross Profit Margin (Quarterly): 32.84% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.84% |
| September 30, 2023 | -30.77% |
| June 30, 2023 | 28.12% |
| March 31, 2023 | -9.91% |
| December 31, 2022 | 46.81% |
| September 30, 2022 | 48.47% |
| June 30, 2022 | 26.05% |
| March 31, 2022 | 34.74% |
| December 31, 2021 | 50.00% |
| September 30, 2021 | 21.10% |
| Date | Value |
|---|---|
| June 30, 2021 | 5.63% |
| March 31, 2021 | 82.14% |
| December 31, 2020 | -5.24% |
| September 30, 2020 | 83.21% |
| June 30, 2020 | 51.88% |
| March 31, 2020 | 51.21% |
| December 31, 2019 | -102.6% |
| September 30, 2019 | 40.67% |
| June 30, 2019 | 59.07% |
| March 31, 2019 | 65.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-102.6%
Minimum
Dec 2019
83.21%
Maximum
Sep 2020
27.02%
Average
34.74%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
| ARCA biopharma Inc | -- |
| Cerus Corp | 55.51% |
| NeuroOne Medical Technologies Corp | 27.24% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -183.1% |
| Return on Assets | -75.85% |
| Return on Invested Capital | -183.1% |
| Profit Margin (Quarterly) | -779.9% |
| Operating Margin (Quarterly) | -1.68K% |
| Return on Net Operating Assets | -412.4% |